申请人:Ayerst, McKenna & Harrison Inc.
公开号:US04369188A1
公开(公告)日:1983-01-18
Herein are disclosed compounds of the formula ##STR1## in which R.sup.1 is hydrogen, lower alkyl or --(CH.sub.2).sub.m --NR.sup.4 R.sup.5 wherein m is an integer from 2 to 6 and R.sup.4 and R.sup.5 each is hydrogen or lower alkyl; R.sup.2 is hydrogen, bromo or chloro; and R.sup.3 is hydrogen or halo; with the requirement that when R.sup.2 is bromo or chloro, then R.sup.3 is bromo or chloro or a therapeutically acceptable salt thereof. The compounds inhibit lens aldose reductase in a diabetic mammal.
本文披露具有以下式子的化合物:##STR1## 其中R.sup.1为氢、低碳基或--(CH.sub.2).sub.m --NR.sup.4 R.sup.5,其中m为2到6的整数,R.sup.4和R.sup.5各为氢或低碳基;R.sup.2为氢、溴或氯;R.sup.3为氢或卤素;要求当R.sup.2为溴或氯时,R.sup.3为溴或氯或其治疗上可接受的盐。这些化合物在糖尿病哺乳动物中抑制晶状体醛还原酶。